Recognition of the disorder called autism may have its origin in Itard's 1801 description of the “wild boy of Aveyron,” a violent child with no language skills who related to other people as if they were objects. It was not until 1943 that Kanner identified a complex set of characteristics (e.g., aberrations in social development, verbal and nonverbal communication, symbolic thinking) for a syndrome he labeled “autism.”

Although Kanner theorized that a single, biologically based defect was responsible for the development of autistic disorders, treatment in the 1950s and 1960s was dominated by the psychodynamic theory of the etiology of autism that charged that pathologic parenting was responsible for the withdrawal of children from their environment. Following the 1970s discovery of neuroreceptors, endogenous neurohormones, and the stereospecific binding sites of neuropeptides to neurons, clinicians have discounted the psychodynamic theory of autism and repostulated Kanner's original supposition that biologically based deficits are responsible for the etiology of autism.

Definition

Autistic disorder is a pervasive developmental disorder defined behaviorally as a syndrome consisting of abnormal development of social skills (withdrawal, lack of interest in peers), limitations in the use of interactive language (speech as well as nonverbal communication), and sensorimotor deficits (inconsistent responses to environmental stimuli).^1,2 In this article, the more generic terms autism and autistic refer to the broad spectrum of pervasive developmental disorders that exhibit autistic features as their primary presenting behaviors. The term autistic disorder is used to describe the specific developmental disorder that occurs at the m TABLE 1

A. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one each from (2) and (3):
	(1) Qualitative impairment in social interaction, as manifested by at least two of the following:
		(a) Marked impairment in the use of multiple nonverbal behaviors such as eye-to-eye gaze, facial expression, body postures, and gestures to regulate social interaction
		(b) Failure to develop peer relationships appropriate to developmental level
		(c) A lack of spontaneous seeking to share enjoyment, interests, or achievements with other people (e.g., by a lack of showing, bringing, or pointing out objects of interest)
		(d) Lack of social or emotional reciprocity
	(2) Qualitative impairments in communication as manifested by at least one of the following:
		(a) Delay in, or total lack of, the development of spoken language (not accompanied by an attempt to compensate through alternative modes of communication such as gesture or mime)
		(b) In individuals with adequate speech, marked impairment in the ability to initiate or sustain a conversation with others
		(c) Stereotyped and repetitive use of language or idiosyncratic language
		(d) Lack of varied, spontaneous make-believe play or social imitative play appropriate to developmental level
	(3) Restricted repetitive and stereotyped patterns of behavior, interest, and activities, as manifested by at least one of the following:
		(a) Encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is abnormal in intensity or focus
		(b) Apparently inflexible adherence to specific, nonfunctional routines or rituals
		(c) Stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting, or complex whole-body movements)
		(d) Persistent preoccupation with parts of objects
B. Delays or abnormal functioning in at least one of the following areas, with onset before three years of age: (1) social interaction, (2) language as used in social communication, or (3) symbolic or imaginative play
C. The disturbance is not better accounted for by Rett's disorder or childhood disintegrative disorder.

Reprinted with permission from the American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994:70–71. Copyright 1994.

ore severely affected end of this spectrum (Table 1).¹

The development of impairments in autistic persons is varied (Table 2¹) and characteristically uneven, resulting in good skills in some areas and poor skills in others. Echolalia, the involuntary repetition of a word or a sentence just spoken by another person, is a common feature of language impairment that, when present, may cause language skills to appear better than they really are. There may also be deficiencies in symbolic thinking, stereotypic behaviors (e.g., repetitive nonproductive movements of hands and fingers, rocking, meaningless vocalizations), self-stimulation, self-injury behaviors, and seizures. Mental retardation is not a diagnostic criterion, but it is frequently present in the moderate to severe range.

Epidemiology

In general, pervasive developmental disorders are estimated to occur at a rate of 63 per 10,000 persons.³ While the reported incidence of autistic disorder ranges from about five per 10,000⁴ to 20 per 10,000 persons,⁵ a recent meta-analysis reports the median rate for 11 surveys conducted since 1989 to be seven per 10,000 persons.⁶ Male-to-female ratios vary with IQ scores from 2:1 in severely handicapped persons to 4:1 in moderately handicapped persons.⁷ [Evidence level B, non-randomized studies] The occurrence rate in siblings is suspected to be from 3 to 7 percent, representing a 50- to 100-fold increase in risk.⁸

Etiology

No single cause has been identified for the development of autism. Genetic origins are suggested by studies of twins and a higher incidence of recurrence among siblings.⁹ In addition, an increased frequency of occurrence is noted in patients with genetic conditions such as fragile X syndrome and tuberous sclerosis.¹⁰ Some reports have suggested a possible association with Down syndrome.¹¹

In addition to the implication of neuro-transmitters, such as serotonin, in the development and expression of autism,¹² many other disorders may result in brain dysfunction. Possible contributing factors in the development of autism include infections, errors in metabolism, immunology, lead poisoning, and fetal alcohol syndrome.¹³

Concerns have been raised in recent years that immunizations, particularly measles, mumps, and rubella (MMR) vaccine, may precipitate autism. In addition to reports from several parents who first detected autism in their children following an MMR vaccination at 12 to 15 months of age, an anecdotal study¹⁴ reported similar suspicions on the part of physicians who provided care for 12 autistic patients. Subsequent studies in the United Kingdom^15,16 [reference 16, Evidence level B: epidemiologic study] and the United States¹⁷ [Evidence level B: epidemio-logic study] have failed to show an association between any vaccine and the development of autism. Information about ongoing studies being conducted by the Centers for Disease Control and Prevention and the National Institutes of Health (NIH) is available at their Web sites (Table 3).

Recognition and Screening

Indications for formal developmental evaluation include no babbling, pointing, or other gestures by 12 months of age, no single words by 16 months of age, no two-word spontaneous phrases by 24 months of age, and loss of previously learned language or social skills at any age.¹⁸ Parental concerns about delayed speech and language development, typically noticed at about 18 months of age, should always be taken seriously.

Including developmental surveillance as a routine part of the well-child examination can enhance recognition of developmental disorders. While the Denver screening tools¹⁹ have historically been used in primary care settings for routine developmental surveillance, they lack the sensitivity and specificity necessary for use as screening tools for developmental disorders.²⁰ More specific and sensitive screening surveillance tools, such as the Parents' Evaluation of Developmental Status (PEDS),²¹ are available for assessing these conditions. Screening tools that are specific for autism include the Checklist for Autism in Toddlers (CHAT)²² (Table 4²³) and the Pervasive Developmental Disorders Screening Test-Stage I (PDDST).²⁴ For a comprehensive review of available screening tools, the authors recommend an article by Filipek and colleagues.¹⁸

When an autistic disorder is suspected, referral should be made for further developmental evaluation and cognitive testing. Although there is currently no cure for autism, early diagnosis and initiation of structured multidisciplinary intervention can significantly enhance functioning in later life.²³ Experienced clinicians can reliably diagnose autism in children younger than three years and, frequently, as young as two years. Presently no biologic markers are available to identify patients with autistic disorders. Useful resources for identifying clinicians with expertise in the diagnosis of autism include the University Affiliated Program system and the National Institute of Child Health and Human Development (Table 3).

Once an autistic disorder is suspected, certain medical evaluations should be performed. A family history of limited cognitive abilities or the presence of dysmorphic features may suggest the need for genetic evaluation. Wood's light examination of the skin should be performed to help identify the depigmented macules of tuberous sclerosis. Lead screening and metabolic testing should be considered if there is a history of lethargy, cyclic vomiting, early seizures, dysmorphic features, or mental retardation. Electrophysiologic testing such as electroencephalography and central nervous system imaging studies are warranted to evaluate neurologic features that cannot be explained by the diagnosis of autism alone.¹⁸ Because deafness or profound hearing loss can cause symptoms mimicking autism, a formal hearing evaluation should be given if the diagnosis of autism is being considered.

Autistic disorders should be distinguished from other psychiatric and pervasive developmental disorders. Table 5¹ lists a differential diagnosis for several similar disorders.

Clinical Course

The typical presenting symptoms of autistic disorder are delayed speech or challenging behavior before three years of age.⁷ Although parents frequently see these signs and suspect that something is wrong with their child by 18 months of age, a diagnosis of autism is frequently delayed by two to three years because of reluctance on the part of clinicians and families to incorrectly label a child as autistic.²⁵ Seventy-five percent of autistic persons have some level of mental retardation.¹ Developmental gains in childhood and adolescence are common, but some persons have behavioral regression during adolescence.

Low IQ scores and failure to develop communicative language by five years of age correlate positively with a poor prognosis for response to treatment.¹ About one third of autistic persons can achieve some degree of independent living,¹ although fewer than 5 percent go on to become self-sufficient adults.¹³ Development of stereotypic behavior, self-injury behavior, and selective attention toward distracting stimuli (e.g., a ticking clock) markedly interfere with structured learning and working environments.¹³

Many autistic persons develop seizures in their first year of life in the form of infantile spasms, a particularly severe form of seizure that is difficult to treat. There is also a significant incidence of first occurrence of seizures during adolescence,²⁶ and as many as 35 percent may develop seizures by adulthood.¹⁸ Comorbid anxiety is common,²⁷ as are depression and obsessional behavior.²⁸

Management of Autism and Comorbid Conditions

The general goals of treatment for autistic patients are to improve language and social skills, decrease problem behaviors, support parents and families in their adjustment to and education of autistic children, and foster independence. Because autistic children who begin treatment at a young age have significantly better outcomes,²⁴ early intervention is critical. Public Law 99-457 and the Individuals with Disabilities Education Act²⁹ mandate referral to the special services departments of local preschool or school systems.

Because no treatment protocol meets the needs of every autistic child, it is helpful to get suggestions from a variety of sources. Organizations available to help families and educators are listed in Table 3.

NEUROPHARMACOLOGIC TREATMENT

Primary care physicians are commonly asked to address the stereotypic or disruptive behaviors of autistic patients. While numerous medications have been used to treat autistic symptoms, no single medication has been shown to be universally effective. Historically, psychotropic medications have been reserved for use in situations where all attempts at behavior management have failed, and the patients are considered to be harmful to themselves or others.

While use of behavior modification programs is often the primary method of managing challenging behaviors in autistic children, supportive medication use has been found to help reduce behavior problems. Obtaining a correct diagnosis is important before initiating any pharmacologic intervention. For example, attention deficit with or without hyperactivity can coexist with autism and may possibly be managed with the use of methylphenidate (Ritalin)³⁰ [Evidence level C: consensus opinion] or clonidine (Catapres).³¹ [Evidence level C: consensus opinion] It can be difficult to distinguish between the behaviors associated with autism; attention-deficit/hyperactivity disorder; and mania, and an appropriate treatment for one disorder may be ineffective or exacerbate the symptoms of another.

When behavior management programs or the use of supportive medications are unsuccessful in correcting potentially dangerous behavior, the use of sedating medications may be necessary for brief periods while less invasive interventions are attempted. Sedative-hypnotics and neuroleptics such as buspirone (BuSpar), in a dosage of 5 to 20 mg two to three times a day³² [Evidence level C: consensus opinion], or risperidone (Risperdal), in a dosage of 0.5 to 2 mg twice a day³³ are commonly used for this purpose. Benzodiazepines should be used with caution because they can cause disinhibition, resulting in more excitable behavior.³²

Objective data collection and outcome monitoring are important because of the variable nature of individual responses to medication. Information should be collected by persons who have regular contact with the patient—family members, support personnel in day care and residential programs, case managers, and physicians. Given the multiple developmental, behavior, and medical problems associated with autism, coordination of services by a multidisciplinary team is highly recommended.³⁴ [Evidence level C: consensus opinion]

ALTERNATIVE THERAPIES

A number of methods for teaching communication and socialization skills have been developed over the years. One recent example is augmented communication, a method whereby nonverbal persons are assisted in communication by means of a letter board or a computer keyboard. When a facilitator helps the person choose letters, words, etc., the process is referred to as facilitated communication. While augmented communication devices have markedly improved communication potential in some patients, numerous controlled studies have failed to show that facilitated communication is reliably useful.¹³

Another treatment currently being advocated is auditory integration training (AIT), whereby persons with autism typically spend 10 hours during a two-week period listening to music that has been computer-modified to remove sensitive frequencies and reduce predictable patterns. AIT is said to improve auditory processing capabilities by correcting distortions in hearing and by conditioning patients to focus their attention more appropriately. Unfortunately, this technique also has little supporting scientific documentation.³⁵

Another popular behavior-based intervention is the Lovaas program,³⁶ sometimes referred to as DTT because of its use of positive reinforcement through a series of intensive discrete trial training sessions. While initial reports suggested a 47 percent recovery rate from autism when preschoolers were treated,³⁶ subsequent studies have been unable to document long-term gains.³⁷ Studies using similar behavior interventions, however, have been able to document short-term improvements.³⁷ Verification of long-term success becomes important in view of the cost of such intensive treatment programs, which typically require extensive one-on-one training with autistic children for 40 hours a week for a minimum of two years—a cost of approximately $40,000 a year.³⁸ Controversies about fiscal responsibility are ongoing because some parents feel local school systems should make this level of care available for their children.³⁸

Other interventional strategies include deep pressure therapy, nutritional supplements, and specialty diets.^39–42 [reference 40, Evidence level A: randomized controlled trial (RCT); reference 42, Evidence level C: consensus opinion] Anecdotal reports of success with alternative or complementary interventions are common, but efficacy in most cases remains clinically unproven. Generally speaking, most successful programs have several common components: (1) recognition of the importance of early identification and intervention; (2) use of behavior-oriented strategies (Table 6¹³); (3) development of social communication; and (4) active involvement of parents and families.

Recently, there has been discussion about a possible role of the gastric hormone secretin as a pharmacologic intervention in the treatment of autism. This information was based on one study of three autistic persons.⁴³ Unfortunately, a subsequent study involving 56 autistic persons failed to support the initial findings.⁴⁴ [Evidence level B: lower quality RCT] At present, most investigators do not see a role for secretin in the treatment of autism, an opinion supported by ongoing research at the NIH.